| Literature DB >> 27689949 |
Michael Sokolov1, Jonathan Ritscher1, Nicola MacKinnon2, Jean-Marc Bielser2, David Brühlmann2, Dominik Rothenhäusler3, Gian Thanei3, Miroslav Soos4, Matthieu Stettler2, Jonathan Souquet2, Hervé Broly2, Massimo Morbidelli1, Alessandro Butté1.
Abstract
This work presents a multivariate methodology combining principal component analysis, the Mahalanobis distance and decision trees for the selection of process factors and their levels in early process development of generic molecules. It is applied to a high throughput study testing more than 200 conditions for the production of a biosimilar monoclonal antibody at microliter scale. The methodology provides the most important selection criteria for the process design in order to improve product quality towards the quality attributes of the originator molecule. Robustness of the selections is ensured by cross-validation of each analysis step. The concluded selections are then successfully validated with an external data set. Finally, the results are compared to those obtained with a widely used software revealing similarities and clear advantages of the presented methodology.Keywords: biosimilars; decision trees; high-throughput process development; multivariate data analysis; principal component analysis; process screening
Mesh:
Substances:
Year: 2016 PMID: 27689949 DOI: 10.1002/btpr.2374
Source DB: PubMed Journal: Biotechnol Prog ISSN: 1520-6033